Literature DB >> 31937626

Anaesthetic management of a parturient with hereditary haemorrhagic telangiectasia (HHT) and pulmonary haemorrhage requiring urgent caesarean section.

Claire Mac Sweeney1, Paula Connolly2, Adrian B Brady3, Áine Cafferkey2.   

Abstract

A 25-year-old gravida 3 para 3 with a history of hereditary haemorrhagic telangiectasia (HHT) and embolised pulmonary arteriovenous malformations (PAVMs) was admitted at 36 weeks gestation with haemoptysis, epistaxis and CT evidence of recent alveolar haemorrhage. An urgent caesarean section was planned. Both previous pregnancies had been delivered by elective lower segment caesarean section (LSCS) under subarachnoid block (SAB) at term. Preanaesthetic planning involved consultation with our tertiary maternity referral centre, the national HHT centre and our tertiary adult referral centre, which has interventional radiology and cardiothoracic capabilities. A whole spine MRI was carried out to rule out vascular malformation. Following multidisciplinary discussion, the decision was made to proceed with caesarean section in our hospital under SAB. Wide bore intravenous access was sited and blood product availability was ensured in case of acute pulmonary haemorrhage. The LSCS was uneventful. Postoperatively following discharge from the hospital, the patient experienced recurrent episodes of small volume haemoptysis, and had further PAVM embolisation in the national HHT centre. This report highlights the difficulties in managing complex parturients in a non-tertiary referral centre and underlines the importance of communication and multidisciplinary team discussion to determine the most appropriate management. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  anaesthesia; haematology (incl blood transfusion); interventional radiology; obstetrics and gynaecology; pregnancy

Mesh:

Year:  2020        PMID: 31937626      PMCID: PMC7021198          DOI: 10.1136/bcr-2019-231120

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Spinal subdural hematoma: a pre-eclamptic patient with a spinal arteriovenous malformation.

Authors:  Yesim Abut; Kerem Erkalp; Basol Bay
Journal:  Anesth Analg       Date:  2006-12       Impact factor: 5.108

2.  Paraplegia caused by spinal angioma--possible association with epidural analgesia.

Authors:  N P Hirsch; C S Child; S A Wijetilleka
Journal:  Anesth Analg       Date:  1985-09       Impact factor: 5.108

3.  Transcatheter embolotherapy of maternal pulmonary arteriovenous malformations during pregnancy.

Authors:  A S Gershon; M E Faughnan; K S Chon; R A Pugash; J A Clark; M J Bohan; K J Henderson; R H Hyland; R I White
Journal:  Chest       Date:  2001-02       Impact factor: 9.410

Review 4.  Hereditary haemorrhagic telangiectasia: a cause of preventable morbidity and mortality.

Authors:  A P Brady; M M Murphy; T M O'Connor
Journal:  Ir J Med Sci       Date:  2008-10-16       Impact factor: 1.568

5.  Pulmonary arteriovenous fistula: mechanical ventilation and hypoxemia.

Authors:  B C Friedman; B J McGrath; J F Williams
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

6.  Estimates of maternal risks of pregnancy for women with hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): suggested approach for obstetric services.

Authors:  C L Shovlin; V Sodhi; A McCarthy; P Lasjaunias; J E Jackson; M N Sheppard
Journal:  BJOG       Date:  2008-05-30       Impact factor: 6.531

Review 7.  Anesthetic implications for the parturient with hereditary hemorrhagic telangiectasia.

Authors:  Suzi Lomax; Hilary Edgcombe
Journal:  Can J Anaesth       Date:  2009-03-28       Impact factor: 5.063

8.  Aortic function during normal human pregnancy.

Authors:  M V Hart; M J Morton; J D Hosenpud; J Metcalfe
Journal:  Am J Obstet Gynecol       Date:  1986-04       Impact factor: 8.661

9.  International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.

Authors:  M E Faughnan; V A Palda; G Garcia-Tsao; U W Geisthoff; J McDonald; D D Proctor; J Spears; D H Brown; E Buscarini; M S Chesnutt; V Cottin; A Ganguly; J R Gossage; A E Guttmacher; R H Hyland; S J Kennedy; J Korzenik; J J Mager; A P Ozanne; J F Piccirillo; D Picus; H Plauchu; M E M Porteous; R E Pyeritz; D A Ross; C Sabba; K Swanson; P Terry; M C Wallace; C J J Westermann; R I White; L H Young; R Zarrabeitia
Journal:  J Med Genet       Date:  2009-06-23       Impact factor: 6.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.